InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Wednesday, 01/13/2021 9:18:41 PM

Wednesday, January 13, 2021 9:18:41 PM

Post# of 14949
Jan.13,2021...H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Sorrento Therapeutics today and set a price target of $30.00. The company’s shares closed last Tuesday at $7.44.

According to TipRanks.com, Selvaraju is a top 100 analyst with an average return of 27.9% and a 69.5% success rate....

Currently, the analyst consensus on Sorrento Therapeutics is a Moderate Buy with an average price target of $30.00.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News